Sinovac Biotech (SVA) Non-Current Deferred Revenue (2009 - 2026)
Sinovac Biotech (SVA) recorded Non-Current Deferred Revenue of $6.08 million in Q2 2026, up 249.1% from $1.74 million a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Non-Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech reported Non-Current Deferred Revenue of $5.89 million, up 21.7% from FY2024.
- Annual Non-Current Deferred Revenue has a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- Across earlier years, Non-Current Deferred Revenue came in at $4.84 million in FY2024 (-17.4%), $5.87 million in FY2023 (+31.0%), $4.48 million in FY2022 (-71.7%) and $15.84 million in FY2021 (+274.5%).
- The Q2 2026 figure is the highest quarterly Non-Current Deferred Revenue since Q2 2022.
- Peak year-over-year performance for Non-Current Deferred Revenue in the last five years was growth of 274.5% in Q4 2021, against a decline of 71.7% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.08 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Jun 30, 2024 | 805,000.00 |
| Dec 31, 2023 | 5.87 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Dec 31, 2022 | 4.48 Mn |
| Jun 30, 2022 | 11.21 Mn |
| Dec 31, 2021 | 15.84 Mn |
| Jun 30, 2021 | 14.59 Mn |
| Dec 31, 2020 | 4.23 Mn |
| Sep 30, 2020 | 13.07 Mn |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 3.40 Mn |
| Dec 31, 2019 | 3.99 Mn |
| Sep 30, 2019 | 2.23 Mn |
| Jun 30, 2019 | 1.80 Mn |
| Mar 31, 2019 | 1.93 Mn |
| Dec 31, 2018 | 5.96 Mn |
API Access
Sinovac Biotech Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();